Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Joachim Schuhmacher is active.

Publication


Featured researches published by Joachim Schuhmacher.


Archive | 1998

Use of central cannbinoid receptor CB1 agonists

Vry Jean-Marie-Viktor Dr. De; Jürgen Dressel; Jürgen Franz; Arno Friedl; Ervin Horvath; Reinhard Prof. Dr. Jork; Michael Matzke; Frank Mauler; Joachim Mittendorf; Joachim Schuhmacher; Peter Spreyer; Verena Vöhringer


Archive | 2003

Isophtalic acid derivatives

Michael Härter; Jens Ergüden; Frank Wunder; Hanna Tinel; Johannes Köbberling; Eva-Maria Becker; Klaus Münter; Karl-Heinz Schlemmer; Raimund Kast; Peter Kolkhof; Gunter Karig; Lars Bärfacker; Walter Hübsch; Joachim Schuhmacher; Susanne Zuleger; Arnel Concepcion; Haruka Shimizu


Archive | 2005

Novel cylopenta[b]benzofuran derivatives and the utilization thereof

Nicole Diedrichs; Thomas Fahrig; Irene Gerlach; Jacques Ragot; Joachim Schuhmacher; Kai Thede; Ervin Horvath


Archive | 2003

Isophthalic acid derivatives

Michael Härter; Jens Ergüden; Frank Wunder; Hanna Tinel; Johannes Köbberling; Eva-Maria Becker; Klaus Münter; Karl-Heinz Schlemmer; Raimund Kast; Peter Kolkhof; Gunter Karig; Lars Bärfacker; Walter Hübsch; Joachim Schuhmacher; Susanne Zuleger; Arnel Concepcion; Haruka Shimizu


Archive | 2006

Acylated nonadepsipeptides II

Franz von Nussbaum; Nina Brunner; Rainer Endermann; Chantal Fürstner; Elke Hartmann; Holger Paulsen; Jacques Ragot; Guido Schiffer; Joachim Schuhmacher; Niels Svenstrup; Joachim Telser; Sonja Anlauf; Michael-Alexander Brüning


Archive | 2001

SUBSTITUTED PHENYLCYCLOHEXANE CARBOXYLIC ACID AMIDES AND THE USE THEREOF

Erwin Bischoff; Thomas Krahn; Stephan-Nicholas Müller; Holger Paulsen; Joachim Schuhmacher; Henning Steinhagen; Wolfgang Thielemann


Archive | 2006

New pyrazol-3-one compounds are hypoxia-inducible transcription factor-prolyl-4-hydroxylase inhibitors useful e.g. to treat and/or prophylaxis heart-circulation diseases, heart failure, anemia, chronic kidney diseases and renal failure

Jens-Kerim Ergüden; Ingo Flamme; Peter Kolkhof; Felix Oehme; Joachim Schuhmacher; Friederike Stoll; Kai Thede; Hanno Wild


Archive | 2009

Substituierte Furane und ihre Verwendung

Raimund Kast; Thomas Lampe; Joachim Schuhmacher; Friederike Stoll


Archive | 2008

Verwendung von acyclisch substituierten Furopyrimidin-Derivaten zur Behandlung der pulmonalen arteriellen Hypertonie

Metin Akbaba; Lars Bärfacker; Hartmut Dr. Beck; Eva-Maria Becker; Alexander Hillisch; Mario Jeske; Gunter Karig; Raimund Kast; Martina Klein; Andreas Dr. Knorr; Thomas Lampe; Mark Dr. Meininghaus; Karl-Heinz Schlemmer; Rudolf Schohe-Loop; Joachim Schuhmacher; Johannes-Peter Stasch; Friederike Stoll


Archive | 2007

Substituierte Furopyrimidine und ihre Verwendung

Hartmut Dr. Beck; Eva-Maria Becker; Mario Jeske; Raimund Kast; Thomas Lampe; Joachim Schuhmacher; Friederike Stoll

Collaboration


Dive into the Joachim Schuhmacher's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Franz von Nussbaum

Bayer HealthCare Pharmaceuticals

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge